Lansoprazole CAS 103577-45-3 Assay 98.0~102.0% (HPLC) API Factory

Inkcazelo emfutshane:

Igama leMichiza: Lansoprazole

CAS: 103577-45-3

Uvavanyo: 98.0~102.0% (HPLC, %w/w)

Imbonakalo: Mhlophe ukuya kwi-Off-White Powder

I-API, iProton Pump Inhibitor (PPI)

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

I-Ruifu Chemical Supply Lansoprazole Intermediates
ILansoprazole CAS 103577-45-3
ILansoprazole Chloride Compound CAS 127337-60-4
(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6

Iipropati zeMichiza:

Igama leMchiza	Lansoprazole
Izithethantonye	2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
Inombolo yeCAS	103577-45-3
Inombolo yeCAT	RF-PI1915
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C16H14F3N3O2S
Ubunzima beMolekyuli	369.36
Indawo yokunyibilika	170℃(Disemba)
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mhlophe ukuya kwi-Off-White Powder
Ukunyibilika	I-Soluble kwi-Dimethylformamide, iphantse inganyibiliki emanzini
Amanzi (KF)	<0.10%
Intsalela kwi-Ignition	<0.10%
Ii-N-Oxides	<0.10%
Sulfone	<0.40%
Sulfidi	<0.10%
Nakuphi na Okunye Ukungcola Okukodwa	<0.10%
Ukungcola ngokupheleleyo	<0.50%
Iintsimbi ezinzima	<10ppm
Indlela yoVavanyo / yoHlahlelo	98.0~102.0% (HPLC, %w/w)
Umgangatho woVavanyo	Pharmacopoeia yaseTshayina
Ukusetyenziswa	I-API, iProton Pump Inhibitor (PPI)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-Lansoprazole (i-CAS: i-103577-45-3) ikwiklasi yeziyobisi ezibizwa ngokuba yiproton pump inhibitors (PPI) ezithintela isisu ekuveliseni i-asidi yesisu.Ezinye iziyobisi kwintsapho ye-PPI ziquka: i-Rabeprazole, i-Omeprazole, i-Pantoprazole, i-Esomeprazole.Iiproton pump inhibitors zisetyenziselwa ukunyanga iimeko ezifana nezilonda, isifo se-gastroesophageal reflux (GERD) kunye ne-Zollinger-Ellison syndrome ebangelwa yi-asidi yesisu.I-Lansoprazole, njengezinye i-proton-pump inhibitors, ivimba i-enzyme kudonga lwesisu oluvelisa i-asidi.Ngokuthintela i-enzyme, ukuveliswa kwe-asidi kuyancipha, kwaye oku kuvumela ukuba isisu kunye ne-esophagus ziphilise.I-Lansoprazole inempembelelo ebalulekileyo yokuthintela kwi-basal gastric acid secretion kunye ne-gastric acid secretion ebangelwa zizo zonke izinto ezikhuthazayo (ezifana ne-histamine, i-carbachol, njl.).I-acid inhibition effect ye-lansoprazole ngokucacileyo ingcono kune-H2 receptor blockers.Iqondo lokuthintela lixhomekeke ekugxininiseni kwe-lansoprazole.Umsebenzi: I-Lansoprazole sisizukulwana esitsha seproton inhibitor, esebenza kwi-loop yokugqibela ye-gastric acid secretion kwaye inqanda kakhulu i-asidi yesisu.ILansoprazole isetyenziselwa ukunyanga isilonda se-duodenal, i-reflux esophagitis kunye nezinye izifo.